A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumoniaC. Avendaño, Rafael F. Duarte, António Ramos et al.|Journal of Clinical Investigation|2021Cited by 110
Convalescent Plasma for COVID-19: A multicenter, randomized clinical trialC. Avendaño, António Ramos, Elena Múñez et al.|medRxiv|2020Cited by 108
Rate and predictors of progression in elite and viremic HIV-1 controllersAgathe León, Felipe García, José María Gatell et al.|AIDS|2016Cited by 84
Factors Leading to the Loss of Natural Elite Control of HIV-1 InfectionMaría Pernas, Ezequiel Ruíz-Mateos, Laura Tarancón‐Díez et al.|Journal of Virology|2017Cited by 78
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Constanza Lucero, Núria Climent et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 65